首页|玉屏风颗粒联合布地奈德与孟鲁司特钠治疗支气管哮喘急性发作患儿的效果

玉屏风颗粒联合布地奈德与孟鲁司特钠治疗支气管哮喘急性发作患儿的效果

扫码查看
目的:观察玉屏风颗粒联合布地奈德与孟鲁司特钠治疗支气管哮喘急性发作患儿的效果.方法:选取 2020 年 10 月至2023 年 10 月该院收治的 86 例支气管哮喘急性发作患儿进行前瞻性研究,按照随机数字表法将其分为研究组与对照组各 43 例.对照组采用布地奈德联合孟鲁司特钠治疗,研究组在对照组基础上增加玉屏风颗粒治疗,比较两组临床疗效,治疗前后肺功能指标[第 1 秒用力呼气容积(FEV1)、用力肺活量(FVC)]水平、气道重塑指标[转化生长因子-β1(TGF-β1)、基质金属蛋白酶-9(MMP-9)]水平、T细胞亚群指标(CD3+、CD4+、CD8+)水平,以及不良反应发生率.结果:研究组治疗总有效率为 95.35%,高于对照组的 79.07%,差异有统计学意义(P<0.05);两组FEV1、FVC水平均高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05);两组TGF-β1、MMP-9 水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组CD3+、CD4+水平均高于治疗前,且研究组高于对照组,两组CD8+水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:玉屏风颗粒联合布地奈德与孟鲁司特钠治疗支气管哮喘急性发作患儿可提高临床疗效与肺功能指标水平,改善T细胞亚群指标水平,降低气道重塑指标水平,其效果优于布地奈德联合孟鲁司特钠治疗.
Effects of Yupingfeng granules combined with Budesonide and Montelukast sodium in treatment of children with acute attack of bronchial asthma
Objective:To observe effects of Yupingfeng granules combined with Budesonide and Montelukast sodium in treatment of children with acute attack of bronchial asthma.Methods:A prospective study was conducted on 86 children with acute attack of bronchial asthma admitted to the hospital from October 2020 to October 2023.According to the random number table method,they were divided into study group and control group,43 cases in each group.The control group was treated with Budesonide combined with Montelukast sodium,while the study group was treated with Yupingfeng granules on the basis of that of the control group.The clinical efficacy,the lung function indexes[forced expiratory volume in one second(FEV1),forced vital capacity(FVC)]levels,airway remodeling indexes[transforming growth factor-β1(TGF-β1),matrix metalloproteinase-9(MMP-9)]levels,and T cell subsets(CD3+,CD4+,CD8+)levels before and after treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of treatment in the study group was 95.35%,which was higher than 79.07%in the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of FEV1 and FVC in the two groups were higher than those before treatment,those in the study group were higher than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of TGF-β1 and MMP-9 in the two groups were lower than those before treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of CD3+and CD4+in the two groups were higher than those before treatment,and those in the study group were higher than those in the control group;the levels of CD8+in the two groups were lower than those before treatment,and that in the study group was lower than that in the control group;and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Yupingfeng granules combined with Budesonide and Montelukast sodium in the treatment of the children with acute attack of bronchial asthma can improve the clinical efficacy and the lung function index levels,improve the levels of T cell subset indexes,and reduce the levels of airway remodeling indexes.Moreover,it is superior to Budesonide combined with Montelukast sodium treatment.

Yupingfeng granulesBudesonideMontelukast sodiumBronchial asthmaLung functionAirway remodeling indexT cell subset

龚辉林

展开 >

固始县妇幼保健院儿科,河南 信阳 465200

玉屏风颗粒 布地奈德 孟鲁司特钠 支气管哮喘 肺功能 气道重塑指标 T细胞亚群

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(16)
  • 12